Subcontract Project/Moffitt/Theoretical/Experiment

$454,586U54FY2014CANIH

Vanderbilt University, Nashville TN

Investigators

Alexander Robertson Allan Andersoncontact

Linked publications & trials

Paper 29590606 Paper 28205616 Paper 27932399 Paper 27383183 Paper 27135974 Paper 26833122 Paper 26360300 Paper 26000030 Paper 25630460 Paper 25600161 Paper 25359461 Paper 25346862 Paper 25306188 Paper 24931675 Paper 24830623 Paper 24696699 Paper 24607745 Paper 24564859 Paper 24511380 Paper 24453958 Paper 24408919 Paper 24065144 Paper 23843616 Paper 23691243 Paper 23427099 Paper 23282288 Paper 22969158 Paper 22964798 Paper 22886092 Paper 22796330 Paper 22511862 Paper 22369188 Paper 22134510 Paper 22121157 Paper 22100414 Paper 21610218 Paper 21465465 Paper 21419156 Paper 21413058 Paper 21300277 Paper 21281571 Paper 21106672 Paper 21064037 Paper 20865159 Paper 20809209 Paper 20802517 Paper 20672321 Paper 20462295 Paper 20407073 Paper 20406449 Paper 20371913 Paper 20354516 Paper 20351797 Paper 20224792 Paper 20074513 Paper 20039268 Paper 19897088 Paper 19896548 Paper 19887618 Paper 19859812 Paper 19718449 Paper 19706777 Paper 19686849 Paper 19566124 Paper 19458499 Paper 19383890 Paper 19324678 Paper 19285513 Paper 19271355 Paper 19250193 Paper 19026711 Paper 18982450 Paper 18839176 Paper 18718759 Paper 18676656 Paper 18662984 Paper 18625060 Paper 18524624 Paper 18515372 Paper 18401665 Paper 18345647 Paper 18273038 Paper 18231661 Paper 18205049 Paper 18188652 Paper 18068192 Paper 17935347 Paper 17677102 Paper 17407594 Paper 17374383 Paper 17129778 Paper 16990258 Paper 15907826

Abstract

During the last 5 years, as we learned how to integrate experimentation with the single mathematical model (HDC) we originally focused on, we gradually expanded into other types of models. We have developed a suite of mathematical and computational models that consider different spatial and temporal scales of tumor progression, so that their application is dictated by a specific biological question. The resolution and scope of each model is largely driven by the specific aspect of tumor progression we are considering in the Projects.

View original record on NIH RePORTER →